Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer

Virology

Volumn 448, Issue , 2014, Pages 356-362

  Chen, Alyce A ^a   Heideman, Daniëlle A M ^b   Boon, Debby ^b   Chen, Zigui ^c   Burk, Robert D ^c   De Vuyst, Hugo ^a   Gheit, Tarik ^a   Snijders, Peter J F ^b   Tommasino, Massimo ^a   Franceschi, Silvia ^a   Clifford, Gary M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cervical cancer; HPV; Phylogeny; Variants

Indexed keywords

DNA; PROTEIN E6; PROTEIN E7;

AFRICA; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA SEQUENCE; EUROPE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 33; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX CANCER;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 33;

EID: 84887512324     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.10.033     Document Type: Article

References (47)

1. Ainsworth J., Thomas M., Banks L., Coutlee F., Matlashewski G. Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses. Virol. J. 2008, 5:67.
2. Alibegashvili T., Clifford G.M., Vaccarella S., Baidoshvili A., Gogiashvili L., Tsagareli Z., Kureli I., Snijders P.J., Heideman D.A., van Kemenade F.J., Meijer C.J., Kordzaia D., Franceschi S. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiol. 2011, 35:465-470.
3. Aruhuri B., Tarivonda L., Tenet V., Sinha R., Snijders P.J., Clifford G., Pang J., McAdam M., Meijer C.J., Frazer I.H., Franceschi S. Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Cancer Prev. Res. 2012, 5:746-753.
4. Bardin A., Vaccarella S., Clifford G.M., Lissowska J., Rekosz M., Bobkiewicz P., Kupryjańczyk J., Krynicki R., Jonska-Gmyrek J., Danska-Bidzinska A., Snijders P.J., Meijer C.J., Zatonski W., Franceschi S. Human papillomavirus infection in women with and without cervical cancer in Warsaw. Poland Eur. J. Cancer 2008, 44:557-564.
5. Beaudenon S., Kremsdorf D., Croissant O., Jablonska S., Wain-Hobson S., Orth G. A novel type of human papillomavirus associated with genital neoplasias. Nature 1986, 321:246-249.
6. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
7. Berumen J., Ordoñez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 2001, 93:1325-1330.
8. Bokal E.V., Kocjan B.J., Poljak M., Bogovac Z., Jančar N. Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. J. Obstet. Gynaecol. Res. 2010, 36:1204-1213.
9. Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., Shah K.V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J. Natl. Cancer Inst. 1995, 87:796-802.
10. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009, 10:321-322.
11. Chen Z., Schiffman M., Herrero R., Desalle R., Anastos K., Segondy M., Sahasrabuddhe V.V., Gravitt P.E., Hsing A.W., Burk R.D. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS ONE 2011, 6:e20183.
12. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J., Vaccarella S., Anh P.T., Ferreccio C., Hieu N.T., Matos E., Molano M., Rajkumar R., Ronco G., de Sanjosé S., Shin H.R., Sukvirach S., Thomas J.O., Tunsakul S., Meijer C.J., Franceschi S. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998.
13. Cole S.T., Streeck R.E. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J. Virol. 1986, 58:991-995.
14. Cornet I., Gheit T., Franceschi S., Vignat J., Burk R.D., Sylla B.S., Tommasino M., Clifford G.M. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 2012, 86:6855-6861.
15. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
16. De Vuyst H., Ndirangu G., Moodley M., Tenet V., Estambale B., Meijer C.J., Snijders P.J., Clifford G., Franceschi S. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int. J. Cancer 2012, 131:949-955.
17. Dondog B., Clifford G.M., Vaccarella S., Waterboer T., Unurjargal D., Avirmed D., Enkhtuya S., Kommoss F., Wentzensen N., Snijders P.J., Meijer C.J., Franceschi S., Pawlita M. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1731-1738.
18. Felsenstein J. Mathematics vs. Evolution: Mathematical Evolutionary Theory. Science 1989, 246:941-942.
19. Franceschi S., Rajkumar T., Vaccarella S., Gajalakshmi V., Sharmila A., Snijders P.J., Muñoz N., Meijer C.J., Herrero R. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int. J. Cancer 2003, 107:127-133.
20. Gagnon S., Hankins C., Tremblay C., Forest P., Pourreaux K., Coutlée F. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. J. Infect. Dis. 2004, 190:1575-1585.
21. Garbuglia A.R., Carletti F., Minosse C., Piselli P., Zaniratti M.S., Serraino D., Capobianchi M.R. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy. N. Microbiol. 2007, 30:377-382.
22. Gheit T., Cornet I., Clifford G.M., Iftner T., Munk C., Tommasino M., Kjaer S.K. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1315-1321.
23. Godínez J.M., Heideman D.A., Gheit T., Alemany L., Snijders P.J., Tommasino M., Meijer C.J., de Sanjosé S., Bosch F.X., Bravo I.G. Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58. Infect. Genet. Evol. 2013, 13:96-104.
24. Goodman M.T., Shvetsov Y.B., McDuffie K., Wilkens L.R., Zhu X., Thompson P.J., Ning L., Killeen J., Kamemoto L., Hernandez B.Y. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res. 2008, 68:8813-8824.
25. Guan P., Howell-Jones R., Li N., Bruni L., de Sanjosé S., Franceschi S., Clifford G.M. Human papillomavirus types in 115,789HPV-positive women: a meta-analysis from cervical infection to cancer. Int. J. Cancer 2012, 131:2349-2359.
26. Hesselink A.T., Berkhof J., Heideman D.A., Bulkmans N.W., van Tellingen J.E., Meijer C.J., Snijders P.J. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. Int. J. Cancer 2009, 124:381-386.
27. Insinga R.P., Dasbach E.J., Elbasha E.H. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect. Dis. 2009, 9:119.
28. Keita N., Clifford G.M., Koulibaly M., Douno K., Kabba I., Haba M., Sylla B.S., van Kemenade F.J., Snijders P.J., Meijer C.J., Franceschi S. HPV infection in women with and without cervical cancer in Conakry. Guinea Br. J. Cancer 2009, 101:202-208.
29. Khouadri S., Villa L.L., Gagnon S., Koushik A., Richardson H., Ferreira S., Tellier P., Simao J., Matlashewski G., Roger M., Franco E.L., Coutlée F. Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J. Infect. Dis. 2006, 194:886-894.
30. Li L.K., Dai M., Clifford G.M., Yao W.Q., Arslan A., Li N., Shi J.F., Snijders P.J., Meijer C.J., Qiao Y.L., Franceschi S. Human papillomavirus infection in Shenyang city, People's Republic of China: A population-based study. Br. J. Cancer 2006, 95:1593-1597.
31. Li N., Franceschi S., Howell-Jones R., Snijders P.J., Clifford G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int. J. Cancer 2011, 128:927-935.
32. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
33. Ntova C.K., Kottaridi C., Chranioti A., Spathis A., Kassanos D., Paraskevaidis E., Karakitsos P. Genetic variability and phylogeny of high risk HPV type 16, 18, 31, 33 and 45 L1 gene in greek women. Int. J. Mol. Sci. 2012, 13:1-17.
34. Plummer M., Schiffman M., Castle P.E., Maucort-Boulch D., Wheeler C.M. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 2007, 195:1582-1589.
35. Raiol T., Wyant P.S., de Amorim R.M., Cerqueira D.M., Milanezi N., Brígido Mde M., Sichero L., Martins C.R. Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. J. Med. Virol. 2009, 81:685-692.
36. Rosa M.I., Fachel J.M., Rosa D.D., Medeiros L.R., Igansi C.N., Bozzetti M.C. Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am. J. Obstet. Gynecol. 2008, 199(617):e611-617.
37. Sathish N., Abraham P., Peedicayil A., Sridharan G., Chandy G. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. Cancer Lett. 2005, 229:93-99.
38. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., Desalle R., Befano B., Yu K., Safaeian M., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Solomon D., Castle P.E., Burk R.D. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70:3159-3169.
39. Sherpa A.T., Clifford G.M., Vaccarella S., Shrestha S., Nygård M., Karki B.S., Snijders P.J., Meijer C.J., Franceschi S. Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control 2010, 21:323-330.
40. Sideri M., Cristoforoni P., Casadio C., Boveri S., Igidbashian S., Schmitt M., Gheit T., Tommasino M. Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine 2009, 27(Suppl. 1):A30-33.
41. Stewart A.C., Eriksson A.M., Manos M.M., Muñoz N., Bosch F.X., Peto J., Wheeler C.M. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol. 1996, 70:3127-3136.
42. Villa L.L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., Franco E.L. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 2000, 81:2959-2968.
43. van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., Snijders P.J. GP5+/6+PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 2002, 40:779-787.
44. Wu X., Zhang C., Feng S., Liu C., Li Y., Yang Y., Gao J., Li H., Meng S., Li L., Zhang Y., Hu X., Wu X., Lin L., Li X., Wang Y. Detection of HPV types and neutralizing antibodies in Gansu province, China. J. Med. Virol. 2009, 81:693-702.
45. Xin C.Y., Matsumoto K., Yoshikawa H., Yasugi T., Onda T., Nakagawa S., Yamada M., Nozawa S., Sekiya S., Hirai Y., Shiromizu K., Fujii T., Taketani Y. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett. 2001, 170:19-24.
46. Zehbe I., Tachezy R., Mytilineos J., Voglino G., Mikyškova I., Delius H., Marongiu A., Gissmann L., Wilander E., Tommasino M. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer 2001, 94:711-716.
47. Zuna R.E., Moore W.E., Shanesmith R.P., Dunn S.T., Wang S.S., Schiffman M., Blakey G.L., Teel T. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 2009, 125:2609-2613.